Literature DB >> 7537777

Evidence that stratum corneum chymotryptic enzyme is transported to the stratum corneum extracellular space via lamellar bodies.

B Sondell1, L E Thornell, T Egelrud.   

Abstract

Stratum corneum chymotryptic enzyme (SCCE) is a recently discovered human serine proteinase that may be specific for keratinizing squamous epithelia. SCCE has properties compatible with a function in the degradation of intercellular cohesive structures during stratum corneum turnover and desquamation. SCCE is expressed in suprabasal keratinocytes. In this study, we demonstrate the subcellular localization of SCCE in the upper granular layer, in the stratum corneum of normal non-palmoplantar skin, and in cohesive parts of hypertrophic plantar stratum corneum, using immunoelectron microscopy of ultrathin cryosections labeled with SCCE-specific monoclonal antibodies detected with gold-labeled secondary antibodies. A narrow zone close to the transition between the granular and cornified layers showed positive SCCE staining after fixation. By means of immunoelectron microscopy, SCCE was found in association with structures resembling intracellular lamellar bodies in the uppermost granular cells and in similar structures undergoing extrusion to the extracellular space between the uppermost granular cells and the lowermost cornified cells. In the stratum corneum, the detected SCCE was confined to the extracellular space and was found in association with intact and partially degraded desmosomes, as well as in the parts of the extracellular space devoid of desmosomes. We conclude that SCCE may be stored in lamellar bodies in the stratum granulosum and transported via these structures to the stratum corneum extracellular space. The results further support the idea that the physiologic function of SCCE may be to catalyze the degradation of desmosomes in the stratum corneum during remodeling of the deeper layers of this tissue, and at a later stage serve as a prerequisite for desquamation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7537777     DOI: 10.1111/1523-1747.ep12607007

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  8 in total

Review 1.  New insights into the functional mechanisms and clinical applications of the kallikrein-related peptidase family.

Authors:  Nashmil Emami; Eleftherios P Diamandis
Journal:  Mol Oncol       Date:  2007-09-15       Impact factor: 6.603

2.  Molecular cloning and characterization of prostase, an androgen-regulated serine protease with prostate-restricted expression.

Authors:  P S Nelson; L Gan; C Ferguson; P Moss; R Gelinas; L Hood; K Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

Review 3.  The pathogenesis of dermatophilosis.

Authors:  N C Ambrose
Journal:  Trop Anim Health Prod       Date:  1996-05       Impact factor: 1.559

4.  Isolation of SPINK6 in human skin: selective inhibitor of kallikrein-related peptidases.

Authors:  Ulf Meyer-Hoffert; Zhihong Wu; Tomasz Kantyka; Jan Fischer; Ties Latendorf; Britta Hansmann; Joachim Bartels; Yinghong He; Regine Gläser; Jens-Michael Schröder
Journal:  J Biol Chem       Date:  2010-07-28       Impact factor: 5.157

5.  Premature terminal differentiation and a reduction in specific proteases associated with loss of ABCA12 in Harlequin ichthyosis.

Authors:  Anna C Thomas; Daniel Tattersall; Elizabeth E Norgett; Edel A O'Toole; David P Kelsell
Journal:  Am J Pathol       Date:  2009-01-29       Impact factor: 4.307

6.  Topical Application of Mesenchymal Stem Cell Exosomes Alleviates the Imiquimod Induced Psoriasis-Like Inflammation.

Authors:  Bin Zhang; Ruenn Chai Lai; Wei Kian Sim; Andre Boon Hwa Choo; Ellen Birgit Lane; Sai Kiang Lim
Journal:  Int J Mol Sci       Date:  2021-01-13       Impact factor: 5.923

7.  Role of Kallikrein 7 in Body Weight and Fat Mass Regulation.

Authors:  Anne Kunath; Juliane Weiner; Kerstin Krause; Maren Rehders; Anastasija Pejkovska; Martin Gericke; Martin L Biniossek; Sebastian Dommel; Matthias Kern; Aleix Ribas-Latre; Oliver Schilling; Klaudia Brix; Michael Stumvoll; Nora Klöting; John T Heiker; Matthias Blüher
Journal:  Biomedicines       Date:  2021-01-29

8.  Identification of lympho-epithelial Kazal-type inhibitor 2 in human skin as a kallikrein-related peptidase 5-specific protease inhibitor.

Authors:  Ulf Meyer-Hoffert; Zhihong Wu; Jens-Michael Schröder
Journal:  PLoS One       Date:  2009-02-03       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.